Insulin resistance is associated with larger thyroid volume in adults with type 1 diabetes independently from presence of thyroid autoimmunity

References

• Klubo-Gwiezdzinska J, Costello J Jr, Patel A, et al. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab. 2013;98:3269–3279.
   PubMed Web of Science ®Google Scholar
• Karimifar M, Aminorroaya A, Amini M, et al. Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: a randomized placebo-controlled clinical trial. J Res Med Sci. 2014;19:1019–1026.
   PubMed Web of Science ®Google Scholar
• Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009;161:599–605.
   PubMed Web of Science ®Google Scholar
• Anil C, Kut A, Atesagaoglu B, et al. Metformin decreases thyroid volume and nodule size in subjects with insulin resistance: a preliminary study. Med Princ Pract. 2016;25:233–236.
   PubMed Web of Science ®Google Scholar
• Sahin M, Ucan B, Ginis Z, et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol. 2013;30:589.
   PubMed Web of Science ®Google Scholar
• Chang CC, Huang CN, Chuang LM. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol. 1998;139:44–48.
   PubMed Web of Science ®Google Scholar
• Barker JM, Yu J, Yu L, et al. Autoantibody “subspecificity” in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care. 2005;28:850–855.
   PubMed Web of Science ®Google Scholar
• Kordonouri O, Klinghammer A, Lang EB, et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care. 2002;25:1346–1350.
   PubMed Web of Science ®Google Scholar
• Sainaghi PP, Castello L, Bergamasco L, et al. Metabolic characteristics of glucose intolerance: the critical role of obesity. Exp Clin Endocrinol Diabetes. 2008;116:86–93.
   PubMed Web of Science ®Google Scholar
• Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D, et al. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease. Exp Clin Endocrinol Diabetes. 2010;118:478–484.
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30:707–712.
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26:1374–1379.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223.
   PubMed Web of Science ®Google Scholar
• Stern SE, Williams K, Ferrannini E, et al. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54:333–339.
   PubMed Web of Science ®Google Scholar
• Williams KV, Erbey JR, Becker D, et al. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000; 49:626–632.
   PubMed Web of Science ®Google Scholar
• Anil C, Akkurt A, Ayturk S, et al. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013;62:970–975.
   PubMed Web of Science ®Google Scholar
• Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:62–69.
   PubMed Web of Science ®Google Scholar
• Rogowicz-Frontczak A, Zozulilska-Ziolkiewicz D, Litwinowicz M, et al. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?1 Eur J Endocrinol. 2014;170:651–658.
   PubMed Web of Science ®Google Scholar
• Rogowicz-Frontczak A, Pilacinski S, Chwialkowska AT, et al. Patients with diabetes type 1 and thyroid autoimmunity have low prevalence of microangiopathic complications. Endocrine. 2016;51:185–188.
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27:84–87.
   PubMed Web of Science ®Google Scholar
• Araszkiewicz A, Rogowicz-Frontczak A, Zozulinska-Ziolkiewicz D, et al. Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy. Scand J Clin Lab Invest. 2011;71:563–568.
   PubMed Web of Science ®Google Scholar
• KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:12–154.
   PubMed Web of Science ®Google Scholar
• Rogowicz-Frontczak A, Araszkiewicz A, Pilacinski S, et al. Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients are dependent on age and mean blood pressure. Exp Clin Endocrinol Diabetes. 2011;119:281–285.
   PubMed Web of Science ®Google Scholar
• Gottsater A, Ryden-Ahlgren A, Szelag B, et al. Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in Type 2 diabetic patients. Diabet Med. 2003;20:495–499.
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119:2886–2893.
   PubMed Web of Science ®Google Scholar
• Yasar HY, Ertugrul O, Ertugrul B, et al. Insulin resistance in nodular thyroid disease. Endocr Res. 2011;36:167–174.
   PubMed Web of Science ®Google Scholar
• Pilacinski S, Wierusz-Wysocka B, Zozulinska-Ziolkiewicz D. Association between serum adiponectin and HbA1c is independent of the severity of clinical presentation in young adults with new onset type 1 diabetes. J Endocrinol Invest. 2016;39:935–937.
   PubMed Web of Science ®Google Scholar
• Cleland SJ, Fisher BM, Colhoun HM, et al. Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? Diabetologia. 2013;56:1462–1470.
   PubMed Web of Science ®Google Scholar
• Bianchi G, Montanari P, Fabbri A, et al. Thyroid volume in type 1 diabetes patients without overt thyroid disease. Acta Diabetol. 1995;32:49–52.
   PubMed Web of Science ®Google Scholar
• Karges B, Muche R, Knerr I, et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab. 2007;92:1647–1652.
   PubMed Web of Science ®Google Scholar
• Korzeniowska K, Ramotowska A, Szypowska A, et al. How does autoimmune thyroiditis in children with type 1 diabetes mellitus influence glycemic control, lipid profile and thyroid volume? J Pediatr Endocrinol Metab. 2015;28:275–278.
   PubMed Web of Science ®Google Scholar
• Chen G, Xu S, Renko K, et al. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metab. 2012;97:510–520.
   PubMed Web of Science ®Google Scholar
• Ittermann T, Markus MR, Schipf S, et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol. 2013;169:9–15.
   PubMed Web of Science ®Google Scholar
• Kaul K, Apostolopoulou M, Roden M. Insulin resistance in type 1 diabetes mellitus. Metab Clin Exp. 2015;64:1629–1639.
   PubMed Web of Science ®Google Scholar
• Knudsen N, Brix TH. Genetic and non-iodine-related factors in the aetiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:495–506.
   PubMed Web of Science ®Google Scholar
• Gietka-Czernel M, Debska M, Kretowicz P, et al. Iodine status of pregnant women from central Poland ten years after introduction of iodine prophylaxis programme. Endokrynol Pol. 2010;61:646–651.
   PubMed Web of Science ®Google Scholar
• Carle A, Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab. 2014;28:465–479.
   PubMed Web of Science ®Google Scholar